DEUTSCHE BANK AG\ - FOAMIX PHARMACEUTICALS LTD ownership

FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 60 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of FOAMIX PHARMACEUTICALS LTD
ValueSharesWeighting
Q3 2019$33,000
-92.7%
10,898
-94.2%
0.00%
Q2 2019$450,000
+800.0%
189,511
+1295.4%
0.00%
Q1 2019$50,000
+47.1%
13,581
+131.1%
0.00%
Q3 2018$34,000
-87.8%
5,877
-89.5%
0.00%
Q2 2018$279,000
+416.7%
55,903
+429.1%
0.00%
Q1 2018$54,000
+3.8%
10,565
+21.4%
0.00%
Q4 2017$52,000
-44.7%
8,706
-49.2%
0.00%
Q3 2017$94,000
-81.3%
17,142
-84.2%
0.00%
Q2 2017$502,000
+112.7%
108,222
+125.9%
0.00%
Q1 2017$236,000
+3.1%
47,898
+132.1%
0.00%
Q4 2016$229,000
-9.1%
20,637
-24.3%
0.00%
Q3 2016$252,000
-55.7%
27,269
-69.6%
0.00%
Q2 2016$569,000
+62.1%
89,665
+65.8%
0.00%
Q1 2016$351,000
-25.3%
54,079
-7.0%
0.00%
Q4 2015$470,000
-10.3%
58,169
-19.0%
0.00%
Q3 2015$524,000
-1.5%
71,806
+38.1%
0.00%
Q2 2015$532,000
+120.7%
52,009
+50.8%
0.00%
Q4 2014$241,000
+36.2%
34,499
+5.8%
0.00%
Q3 2014$177,00032,6090.00%
Other shareholders
FOAMIX PHARMACEUTICALS LTD shareholders Q2 2019
NameSharesValueWeighting ↓
DSC Advisors, L.P. 1,667,377$15,440,0009.38%
GREAT POINT PARTNERS LLC 2,769,425$25,645,0006.54%
Opaleye Management Inc. 630,000$5,834,0003.05%
Vivo Capital, LLC 855,000$7,917,0002.47%
DAFNA Capital Management LLC 278,067$2,575,0001.79%
RA Capital Management 1,820,138$16,854,0001.74%
SENZAR ASSET MANAGEMENT, LLC 523,397$4,846,656,0001.25%
Perceptive Advisors 1,373,284$12,717,0000.82%
Monashee Investment Management LLC 225,000$2,084,0000.73%
NEXTHERA CAPITAL LP 125,000$1,158,0000.71%
View complete list of FOAMIX PHARMACEUTICALS LTD shareholders